Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2012

Evolving Systems, Inc. (EVOL) Announces Reaching 75 Million SIM Card Activations, Bolstering Its Leadership in the Dynamic Provisioning Industry

Evolving Systems, a leading provider of software solutions and services to the wireless, wireline, and cable markets, has reached an impressive milestone that demonstrates its leadership in the dynamic provisioning market space. Evolving Systems’ Dynamic SIM Allocation™ solution has activated … Continue reading

Posted in Small Cap News | Leave a comment

FluoroPharma Medical, Inc. (FPMI) In Summary

FluoroPharma Medical, a developer of imaging agents for use with positron emission tomography (PET) scanning, helps to make visible subtle biological processes occurring deep within the body. From its founding in 2003, with technology licensed from Massachusetts General Hospital, the … Continue reading

Posted in FluoroPharma Medical Inc. FPMI | Leave a comment

Palatin Technologies, Inc. (PTN) Announces Start of Second Phase I Trial of Its Obesity Compound

Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and significant commercial potential. Obesity is also a focus of the company. Palatin Technologies reported today that a second Phase … Continue reading

Posted in Small Cap News | Leave a comment

Intellicheck Mobilisa, Inc. (IDN) Announces New Patent

Yesterday, Intellicheck Mobilisa announced the issuance of U.S. Patent No. 8,139,869 relating to a document comparison system. The issuance of this patent removes limitations on a previously issued patent, and brings the company’s current portfolio of U.S. patents up to … Continue reading

Posted in Small Cap News | Leave a comment

NeuroMetrix, Inc. (NURO) Files 510(k) for Pain Therapy Device

Yesterday, medical device company NeuroMetrix announced that it has filed a 501(k), also known as a premarket notification, with the Food and Drug Administration for its SENSUS Pain Therapy device. SENSUS is a non-invasive transcutaneous electrical nerve stimulator that is … Continue reading

Posted in Small Cap News | Leave a comment

GlobalWise Investments, Inc. (GWIV) Helps CareWorks Solve Complex Medical Claims Processing Challenges

GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today provided investors with a case study … Continue reading

Posted in GlobalWise Investments Inc. GWIV | Leave a comment

Cardium Therapeutics Inc. (CXM) Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care

Cardium Therapeutics is currently exhibiting its new FDA-cleared Excellagen® professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers and other dermal wounds at the 2012 Spring Symposium on Advanced Wound Care (SAWC) being held April … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Tri-Valley Corp. (TIV) Reports FY11 Financials and Operational Update

Tri-Valley, the name behind a growing footprint of oil and natural gas E&P infrastructure in CA (specifically the Pleasant Valley Oil Sands Project in the Oxnard Oil Field and the Claflin Project in the Edison Field), as well as two … Continue reading

Posted in Small Cap News | Leave a comment

Augme Technologies, Inc. (AUGT) Subsidiary Partners with BBB Mobile Giving Foundation to Extend Non-Profit Efforts

Hipcricket, wholly owned subsidiary of Augme Technologies, is a mobile marketing and advertising company focused on helping brands, agencies, and media properties to engage customers, drive loyalty, and increase sales. The company today announced an association with the BBB Mobile … Continue reading

Posted in Small Cap News | Leave a comment

Metabolix, Inc. (MBLX) Opens First International Office in Cologne, Germany

Bioscience company Metabolix announced today the launch of a new office in Cologne, Germany, which opened its doors on April 16. The space, located in the BioCampus Cologne life science park, will give the company direct access to the European … Continue reading

Posted in Small Cap News | Leave a comment